Literature DB >> 31116090

Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.

Shenglong Li1, Yi Pei1, Wei Wang1, Fei Liu1, Ke Zheng1, Xiaojing Zhang1.   

Abstract

Circular RNAs (circRNAs) are recently emerged to be promising therapeutic targets of tumors. Osteosarcoma is the most prevalent primary bone tumor and the third most prevalent cancer in children and adolescents. This study firstly analyzed circRNA microarray of osteosarcoma and selected circ-0001785 as the study object. We aimed to comprehensively investigate the expression pattern and biological function of circ-0001785 in the progression of osteosarcoma. Relative levels of circ-0001785 and miR-1200 in the normal human osteoblast cell line and osteosarcoma cell lines were determined. Bioinformatics analyses predicted the binding relationship between miR-1200 to HOXB2 and circ-0001785, while dual-luciferase reporter gene assay further verified this relationship. Flow cytometry and EdU assay were used for evaluating the regulatory effects of circ-0001785/miR-1200/HOXB2 axis on osteosarcoma cells. Consistent with the microarray analysis, circ-0001785 was highly expressed in osteosarcoma cell lines. Knockdown of circ-0001785 attenuated proliferative ability, but induced the apoptosis of osteosarcoma cells. Furthermore, we confirmed that circ-0001785 competitively bound to miR-1200, thus up-regulating its target gene HOXB2. Western blot analyses revealed that circ-0001785 regulated the PI3K/Akt signaling and Bcl-2 family pathway in osteosarcoma. In conclusion, circ-0001785 regulates the pathogenesis of osteosarcoma by sponging miR-1200 to up-regulate HOXB2 expression.

Entities:  

Keywords:  Osteosarcoma; apoptosis; circRNA; competing endogenous RNAs (ceRNA); proliferation

Mesh:

Substances:

Year:  2019        PMID: 31116090      PMCID: PMC6592237          DOI: 10.1080/15384101.2019.1618127

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  33 in total

Review 1.  Attacking cancer's Achilles heel: antagonism of anti-apoptotic BCL-2 family members.

Authors:  Joseph T Opferman
Journal:  FEBS J       Date:  2015-09-15       Impact factor: 5.542

Review 2.  miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart.

Authors:  Bianca C Bernardo; Jenny Y Y Ooi; Ruby C Y Lin; Julie R McMullen
Journal:  Future Med Chem       Date:  2015-09-24       Impact factor: 3.808

3.  Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma.

Authors:  Nian Deng; Longyang Li; Jinghao Gao; Jun Zhou; Yan Wang; Chao Wang; Yong Liu
Journal:  Biochem Biophys Res Commun       Date:  2017-11-05       Impact factor: 3.575

Review 4.  Understanding osteosarcomas.

Authors:  Emily Simpson; Heather L Brown
Journal:  JAAPA       Date:  2018-08

5.  Lung cancer susceptibility genetic variants modulate HOXB2 expression in the lung.

Authors:  Alisson Clemenceau; Olivier Boucherat; Kim Landry-Truchon; Maxime Lamontagne; Sabrina Biardel; Philippe Joubert; Stéphane Gobeil; Blandine Secco; Mathieu Laplante; Mathieu Morissette; Ma'en Obeidat; Wim Timens; Lucie Jeannotte; Yohan Bossé
Journal:  Int J Dev Biol       Date:  2018       Impact factor: 2.203

Review 6.  Osteosarcoma treatment - where do we stand? A state of the art review.

Authors:  Anja Luetke; Paul A Meyers; Ian Lewis; Heribert Juergens
Journal:  Cancer Treat Rev       Date:  2013-11-27       Impact factor: 12.111

Review 7.  Advances in targeted therapy for osteosarcoma.

Authors:  Wenya Zhou; Mengze Hao; Xiaoling Du; Kexin Chen; Guowen Wang; Jilong Yang
Journal:  Discov Med       Date:  2014-06       Impact factor: 2.970

8.  HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.

Authors:  Kentaro Inamura; Yuki Togashi; Hironori Ninomiya; Takashi Shimoji; Tetsuo Noda; Yuichi Ishikawa
Journal:  Anticancer Res       Date:  2008 Jul-Aug       Impact factor: 2.480

9.  Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA/VEGFR2 signaling pathway.

Authors:  Zhenyu Zhong; Mengge Huang; Mengxin Lv; Yunfeng He; Changzhu Duan; Luyu Zhang; Junxia Chen
Journal:  Cancer Lett       Date:  2017-07-04       Impact factor: 8.679

10.  Circular RNAs promote TRPM3 expression by inhibiting hsa-miR-130a-3p in coronary artery disease patients.

Authors:  Ren-You Pan; Jun Song; Ping Liu; Hai-Tang Zhou; Wei-Xin Sun; Jiang Shu; Guo-Jing Cui; Zhi-Jian Yang; En-Zhi Jia
Journal:  Oncotarget       Date:  2017-08-04
View more
  21 in total

1.  Circ_0085315 promotes cell proliferation, invasion, and migration in colon cancer through miR-1200/MAP3K1 signaling pathway.

Authors:  Yuan Luo; Qi Yao
Journal:  Cell Cycle       Date:  2022-03-01       Impact factor: 5.173

2.  Circular RNA hsa_circ_0005909 modulates osteosarcoma progression via the miR-936/HMGB1 axis.

Authors:  Shuai Ding; Guangquan Zhang; Yanzheng Gao; Shulian Chen; Chen Cao
Journal:  Cancer Cell Int       Date:  2020-07-13       Impact factor: 5.722

3.  Hsa_circ_0010220 regulates miR-198/Syntaxin 6 axis to promote osteosarcoma progression.

Authors:  Zhaoan Lu; Chuanwen Wang; Xiaolong Lv; Wen Dai
Journal:  J Bone Oncol       Date:  2021-04-22       Impact factor: 4.072

4.  LINC00662 promotes cell viability and metastasis in esophageal squamous cell carcinoma by sponging miR-340-5p and upregulating HOXB2.

Authors:  Zhimei Zhang; Xuyang Liang; Ling Ren; Shuxian Zhang; Shouying Li; Tongxun Wan; Dazhou Xu; Shengxiang Lv
Journal:  Thorac Cancer       Date:  2020-07-07       Impact factor: 3.500

5.  LncRNA RGMB-AS1 Promotes Glioma Growth and Invasion Through miR-1200/HOXB2 Axis.

Authors:  Bailin Pan; Ming Zhao; Ning Wang; Longbiao Xu; Tianya Wu; Zequn Li
Journal:  Onco Targets Ther       Date:  2019-11-25       Impact factor: 4.147

6.  A novel identified circular RNA, circ_0000491, aggravates the extracellular matrix of diabetic nephropathy glomerular mesangial cells through suppressing miR‑101b by targeting TGFβRI.

Authors:  Xin Mou; Jia Wei Chenv; Di Yi Zhou; Kaiyuan Liu; Li Jun Chen; Danyang Zhou; Yong Bin Hu
Journal:  Mol Med Rep       Date:  2020-09-02       Impact factor: 2.952

7.  lncRNA IGHCγ1 Acts as a ceRNA to Regulate Macrophage Inflammation via the miR-6891-3p/TLR4 Axis in Osteoarthritis.

Authors:  Pengjun Zhang; Jianmei Sun; Caihong Liang; Bingjie Gu; Yang Xu; Hongying Lu; Bo Cao; Hao Xu
Journal:  Mediators Inflamm       Date:  2020-01-17       Impact factor: 4.711

8.  Circular RNA circ_0026359 Enhances Cisplatin Resistance in Gastric Cancer via Targeting miR-1200/POLD4 Pathway.

Authors:  Zongyao Zhang; Xin Yu; Bo Zhou; Jiajia Zhang; Jiacong Chang
Journal:  Biomed Res Int       Date:  2020-08-13       Impact factor: 3.411

9.  Upregulation Of circMMP9 Promotes Osteosarcoma Progression Via Targeting miR-1265/CHI3L1 Axis.

Authors:  Guangjie Pan; Ting Hu; Xuewu Chen; Chao Zhang
Journal:  Cancer Manag Res       Date:  2019-10-29       Impact factor: 3.989

10.  Circular RNA_CNST Promotes the Tumorigenesis of Osteosarcoma Cells by Sponging miR-421.

Authors:  Ji-Hai Wang; Xue-Jian Wu; Yong-Zhuang Duan; Feng Li
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.